Cdmo Services

KD LabService

Explore about our broad range of CDMO Services and Products

Lipids
Small Molecules
Finished dosage forms
Pharma
Omega-3 Fish & Algae Cannabinoid Solutions
Pharma Lipids
API’s & Intermediates Synthetic Cannabinoids
Pharma Small Molecules
Coming soon!
Pharma FDF
Nutra
Omega-3 Fish & Algae Solutions Cannabinoid Solutions
Nutra Lipids
Fine Chemicals
Nutra Small Molecules
Softgels, Liquids & Finished Packaging
Nutra FDF

Explore about our broad range of CDMO Services and Products

Pharma

Lipids

Omega-3 Fish & Algae Cannabinoid Solutions

Small molecules

API’s & Intermediates Synthetic Cannabinoids

Finished dosage forms

Coming soon!

Nutra

Lipids

Omega-3 Fish & Algae Solutions Cannabinoid Solutions

Small molecules

Fine Chemicals

Finished dosage forms

Softgels, Liquids & Finished Packaging

Reports

Financial publications

Here you will find all the O3 Holding GmbH (KD Pharma Group) financial publications:

Go to files
2025

Q3 Financial Publications:

KD Pharma Group Interim Report Q3 2025
Unaudited Unconsolidated Interim Financial Statement Q3 2025 

Q2 Financial Publications:

KD Pharma Group Interim Report Q2 2025
Unaudited Unconsolidated Interim Financial Statement Q2 2025

Q1 Financial Publications:

KD Pharma Group Interim Report Q1 2025
Unaudited Unconsolidated Interim Financial Statement Q1 2025
Publication Q1 2025 Interim Report and change of CFO
Go to files
2024

Annual Report:

Full Year Report 2024
Full Final German Version PWC Consolidated Accounts 2024
06/25 Publication Annual Report 2024
05/20 Delayed Publication Annual Report 2024
04/30 Delayed Publication Annual Report 2024

Q4 Financial Publications:

Unaudited Unconsolidated Interim Financial Report Q4 2024
Statements & Notes Unconsolidated 2024 - English
Statements & Notes Unconsolidated 2024 - German